Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

238 Views

Poster Session: Virology: Treatment and Prevention of Viral Infections

1466 - Antiretroviral (ART) Virologic Suppression (VS) and Patient Reported Outcomes (PROs) at 6 Months in the Clinical Opportunities and Management to Exploit Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) an Asynchronous Connection Key (COMEBACK) Study

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Lindsey Roden, MA, MPH

Research Coordinator
The Ruth M. Rothstein CORE Center
Chicago, Illinois, United States

Co-Author(s)

GH

Gregory Huhn, MD, MPHTM

Attending Physician
The Ruth M. Rothstein CORE CENTER
Chicago, Illinois, United States
CD

Camille E. DeMarco, MPH, CPH

The Ruth M. Rothstein CORE Center
Chicago, Illinois, United States
KK

Kody Keckler, BA

The Ruth M. Rothstein CORE Center
Chicago, Illinois, United States
PC

Patricia Cortes Valadez, BSN, RN

The Ruth M. Rothstein CORE Center
Chicago, Illinois, United States
KB

Kerianne Burke, MPH

The Ruth M. Rothstein CORE Center
Chicago, Illinois, United States